IRD
Opus Genetics·NASDAQ
--
--(--)
--
--(--)
6.40 / 10
Outperform
Liquidity flow is robust (7.31/10), showing strong fund inflow despite mixed pattern trends. The analyst community is overwhelmingly bullish with a 100% Strong Buy rating from two BTIG predictions, both historically accurate. This positive sentiment partially offsets technical and fundamental weaknesses, but investors should still monitor cash-flow sustainability and technical breakouts.
Fund Flow Rating
Analyst RatingStrong Buy
Wall Street Opinions
Strong Buy
Strong Buy
100%
Buy
0%
Hold
0%
Sell
0%
Strong Sell
0%
Date2026-01-28
InstitutionBTIG
Times predicted2
Historical Win Rate100.0%
What is the market sentiment for IRD?
- IRD holds a Bullish analyst rating, with 100% of experts assigning a Strong Buy grade. Factoring in net Outflows from order flow data, the comprehensive Sentiment Score stands at 6.40/10 (Outperform).
